Scope
NICE NG84 addresses acute sore throat, including pharyngitis and tonsillitis, with a focus on symptom relief and selective antibiotic use. The pathway uses FeverPAIN or Centor scores alongside illness severity. Serious systemic infection and suppurative complications require escalation regardless of a routine outpatient score.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Assess severity and likely benefit from antibiotics
- Acute sore throat is usually self-limiting, often viral, and can last around 1 week. Most people improve without antibiotics regardless of bacterial or viral cause. Give advice about pain, fever, hydration and the expected course. [1]
- Use FeverPAIN or Centor to assess likely antibiotic benefit. Children under 5 with fever also need assessment under the separate fever guideline. [1]
- Reassess rapid or substantial worsening, considering scarlet fever, glandular fever, a serious alternative illness and resistance after previous antibiotics. [1]
- For FeverPAIN 0–1 or Centor 0–2, do not offer antibiotics. Advise review if symptoms worsen rapidly or significantly, have not begun improving after 1 week or the person becomes systemically very unwell. [1]
- For FeverPAIN 2–3, consider no antibiotic with advice or a back-up prescription. Antibiotics shorten symptoms by about 16 hours on average; most people recover within 1 week either way, and nausea or diarrhoea may occur. [1]
- For FeverPAIN 4–5 or Centor 3–4, consider an immediate or back-up antibiotic. This remains a conditional choice weighing the low complication likelihood against adverse effects. [1]
Explain delayed treatment and urgent escalation
- A back-up prescription is not needed immediately. Use it if symptoms do not start improving within 3–5 days or deteriorate rapidly or significantly at any time. Worsening symptoms or becoming systemically very unwell requires medical review. [1]
- Offer an immediate antibiotic when the person is systemically very unwell, has features of a more serious illness or is at high risk of complications. Give safety-net advice even when immediate antibiotics are supplied. [1]
- Refer to hospital for severe systemic infection or severe suppurative complications such as peritonsillar abscess or cellulitis, parapharyngeal or retropharyngeal abscess, or Lemierre syndrome. [1]
Use the appropriate antibiotic table
- For adults aged at least 18 when antibiotics are indicated, first choice is phenoxymethylpenicillin 500 mg four times daily or 1,000 mg twice daily for 5–10 days. Five days may relieve symptoms, while 10 days may improve microbiological cure. [1]
- For non-pregnant adults with penicillin allergy or intolerance, NICE lists clarithromycin 250–500 mg twice daily for 5 days. In pregnancy, erythromycin is preferred if a macrolide is needed and the treatment benefits outweigh harms. [1]
- Children and young people under 18 need the paediatric antibiotic table. Age bands assume average size and must be considered with severity and the child’s actual size. Check appropriate dosing for renal or hepatic impairment and other specific populations. [1]
Treat discomfort and maintain hydration
- Consider paracetamol for pain or fever, or ibuprofen when preferred and suitable. Advise adequate fluid intake. [1]
- Adults may try a medicated lozenge containing a local anaesthetic, NSAID or antiseptic, but the likely pain benefit is small. NICE found no evidence for non-medicated lozenges, mouthwashes or a local anaesthetic spray used alone. [1]
Limitations and use
- This is the NICE UK acute sore-throat pathway. It does not establish a universal testing or rheumatic-fever prevention strategy for every country or higher-risk population; use relevant regional guidance.
- The complete FeverPAIN and Centor component definitions, paediatric doses and pregnancy erythromycin schedule are not reproduced here. Verify them in the original tools and prescribing tables.
- The score-based choices apply to routine assessment and do not override urgent referral for severe systemic illness or suppurative complications.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Sore throat (acute): antimicrobial prescribing
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 26 January 2018
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.